Novo Nordisk’s next-generation weight-loss drug CagriSema
Dec 20, 2024 · Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently approved medicine, Zepbound, but didn’t cleanly surpass it in...
Novo Nordisk shares plunge after CagriSema obesity drug trial …
Dec 20, 2024 · LONDON/COPENHAGEN (Reuters) -Novo Nordisk on Friday revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug CagriSema, wiping as much as $125...
Latest news - Novo Nordisk
Dec 15, 2024 · We plan to invest 2.9 billion Danish kroner to establish a cutting-edge quality control laboratory in Hillerød, Denmark. Environmental challenges have never been more critical or more urgent than they are today. But at Novo Nordisk, we never allow complexity to become a barrier to change.
Novo Nordisk shares plunge 20% after disappointing trial results; …
Dec 20, 2024 · Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 24% at one point Friday after reporting trial results that missed expectations.
Compounded semaglutide associated with at least 10 deaths, Novo Nordisk …
Nov 6, 2024 · Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths, the chief...
Company announcements & press releases - Novo Nordisk
Product-related press releases will only be available upon request after three weeks of publication on our website in order to comply with applicable regulation.
Novo Nordisk shares tumble as data on weight-loss drug trial …
Dec 20, 2024 · Novo Nordisk and Eli Lilly are competing for dominance in a market that grew sevenfold in just three years to $24bn in 2023, according to data analytics firm Iqvia.
US FDA approves Novo Nordisk's bleeding disorder drug
Dec 20 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's (NOVOb.CO), opens new tab drug for the prevention or reduction of bleeding episodes in patients with a type of ...
News & media - Novo Nordisk
Get an overview of the Novo Nordisk press releases here or subscribe to our news and get it directly in your mailbox when we have news to tell.
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and …
Dec 20, 2024 · Bad news for Novo Nordisk (NVO 0.34%) Friday was good news for Eli Lilly (LLY-0.24%) and Viking Therapeutics (VKTX 1.18%), its two main rivals in the field of weight loss drugs.This morning, Novo ...